Newer-generation clot-busting drug outperforms traditional stroke treatment in many areas
A newer-generation clot-busting drug called tenecteplase outperforms the traditional treatment for ischemic strokes in several key areas, including better health outcomes and lower costs, according to a new study published today in the American Stroke Association's journal Stroke.
Source: news-medical.net